title: Pulmonary pneumocystosis in a patient with greater than 500 CD4 cells/microl: a role for IL-2 therapy?
authors.forename: Camille
authors.initials: C
authors.lastname: Fontaine
authors.forename: Philippe
authors.initials: P
authors.lastname: Bonnard
authors.forename: Murielle
authors.initials: M
authors.lastname: Mary-Krause
authors.forename: Patrice
authors.initials: P
authors.lastname: Callard
authors.forename: Gilles
authors.initials: G
authors.lastname: Pialoux
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D008297:Male; D011020:Pneumonia, Pneumocystis / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D019380:Anti-HIV Agents; D007376:Interleukin-2